Julia Hoveyan: What an Amazing Experience at This Year’s 30th Annual Meeting and Education Day of the SNO
Julia Hoveyan, Pediatric Oncologist at Pediatric Cancer and Blood Disorders Center of Armenia, Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“What an amazing experience at this year’s 30th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) in beautiful Honolulu!
The meeting was a tremendous success, featuring state-of-the-art lectures, cutting-edge scientific updates, and exceptional networking opportunities with leaders and colleagues in neuro-oncology.

I was extremely honored to deliver an oral presentation during the scientific program, presenting the results of our collaborative study conducted at the Immune Oncology Research Institute, which mapped the global landscape of glioblastoma clinical trials and highlighted critical gaps in low- and middle-income countries (LMICs). Sharing this work on such a prestigious platform was an incredible privilege.
This achievement was only possible thanks to the dedicated team standing behind this work. Gevorg Tamamyan, Ruzanna Papyan, Ibrahim Qaddoumi, Ina Khachatryan, Mane Ghevondyan, Lena Mkrtchyan, Elen Baloyan, Immune Oncology Research Institute
Special thanks to the H. Hovnanian Family Foundation Armenia and Health Fund for Children of Armenia for the travel grant and the opportunity to participate in this wonderful event.
Feeling inspired by the innovative research and collaborative spirit driving progress in neuro-oncology!”
Be first to know with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
